Lydus Medical, based in Ra’anana, Israel, develops a novel product line to automate creation of small blood vessel anastomoses. Its lead product, the Vesseal, enables precise, symmetrical and rapid connection of blood and lymph vessels from 4.0 to 0.5mm for procedures including breast reconstruction, lymphedema treatment, bypass surgery and hemodialysis access. The company’s pipeline includes a diverse portfolio of products all based on a patented invention. Led by CEO Jessica Weiss, Lydus plans to use the funding to accelerate FDA clearance, scale product development and prepare for market entry. The company raised $2.7m in a Pre-A funding round.

Total raised

$3M

Funding rounds

1

Latest round

Series A

Latest activity

May 2021